We recently reported that in mouse models of colon cancer, the combination of a viral-CEA vaccine with anti-PD-1 antibody resulted in greater antitumor activity and immune responses compared with vaccination against CEA alone.32 This evidence concerns the gene CEACAM5 and colonic neoplasm.